Find and Pitch Jounalists, Get Your Story Covered

Tags: toyota integra honda civic bradley brownell bentley arnage

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	RSV in Older Adults: Risks, Prevention, and the Pharmacist's Role - 17 days ago Rise in RSV Infections Is Associated With a Decrease in Vaccine Hesitancy - about 2 months ago Study Suggests Weakened RSV Vaccine Response in Immunocompromised Individuals - 2 months ago Protecting High-Risk Adults from Severe RSV: New Vaccination Recommendations and Strategies - 3 months ago Study Results Show 1 in 20 Adults With RSV Are Hospitalized - 3 months ago Researchers Highlight Need for Increased RSV Vaccination - 4 months ago RSV Preventative Monoclonal Antibody Could Reduce Disease Incidence in Preterm, Full-term Infants - 4 months ago Public Concern of RSV Infection Has Decreased as Flu and COVID-19 Remain a Worry - 4 months ago Single Dose of Abrysvo Could Provide Immune Protection Against RSV in Immunocompromised Individuals - 6 months ago Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses - 7 months ago ACIP Releases Updated RSV Recommendations - 8 months ago CDC Evaluates Concerns of Guillain-Barré Syndrome Following RSV Vaccination - 9 months ago Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults - 11 months ago Study Shows Low Number of Older Americans Are Vaccinated Against RSV - 12 months ago Implement the 3C Model of Vaccine Hesitancy, RSV Risk in Older Adults - about 1 year ago Study: If 66% of Adults 60 and Older Receive RSV Immunization, Infections Can Be Reduced - about 1 year ago Study: Low RSV Vaccination Coverage Among Nursing Home Residents - about 1 year ago Researchers Evaluate New Advancements for RSV Management, Treatment - about 1 year ago Researchers Classify Children Most at Risk for Respiratory Syncytial Virus - over 1 year ago
2	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Older Immunocompromised Folks May Need More From RSV Vaccines - 2 months ago
3	Jennifer Henderson MedPage Today Enterprise & Investigative Writer. Works with MedPage Today. Enterprise writinginvestigative journalismhealthcare	FDA Advisors Say More Data Needed for RSV Vaccines in Young Kids - 3 months ago Should RSV Vaccination Expand to Younger High-Risk Groups? - 3 months ago Which High-Risk Patients Should Get the RSV Vaccine? - 4 months ago Real-World Data on the RSV Vaccine for Older Adults - 4 months ago RSV Vaccines Show High Effectiveness Against Hospitalization in Older Adults - 6 months ago Clinical Challenges: Test Your Knowledge on Pediatric Vaccines - over 1 year ago Clinical Challenges: Navigating New RSV Protections for the Youngest Kids - over 1 year ago Clinical Challenges: Discussing Childhood Vaccination With Hesitant Parents - over 1 year ago CDC Advisors Endorse Maternal RSV Vax to Protect Newborns - over 1 year ago
4	Katherine Kahn MedPage Today Physician-Scientist. Studies Long Covid. United States medicineLong Covid	RSV Vaccine Tied to Fewer Hospitalizations, ED Visits in Older, High-Risk Adults - 4 months ago Novel Monoclonal Antibody Protects Infants Against RSV - 5 months ago Maternal RSV Vaccine Appears Safe, Real-World Study Finds - 8 months ago CDC Monitoring Rare Neurologic Events After RSV Vaccination - about 1 year ago ACIP Unveils Its 2024 Adult Immunization Recommendations - about 1 year ago Pediatric RSV Led to Higher Hospitalization Rates than Omicron or Flu - about 1 year ago
5	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Pfizer, GSK and Moderna execs remain optimistic about RSV vaccines despite CDC blowback - 7 months ago
6	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab - 10 months ago
7	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	Pfizer’s plot to win the RSV vaccine race - 11 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Safety Data Confirm Viability of Flu, RSV Vaccines For Patients at Risk of Heart Failure - 11 months ago RSV Season 2022: Most US Infants in ICU Were Full-Term, Previously Healthy - over 1 year ago CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV - over 1 year ago Arexvy Shows Non-Inferior Immune Response Against Lower Respiratory Tract Disease From RSV - over 1 year ago Webinar: Demand of Respiratory Illness Vaccines Exceeds Availability - over 1 year ago
9	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Pharmacist's Vital Role in RSV Vaccination: Shared Clinical Decision Making and Education - 12 months ago
10	Nicoletta Lanese Live Science Science journalist. New York, USA sciencehealthjournalism	RSV vaccine keeps older adults highly protected for at least 2 seasons - about 1 year ago